Table 2.
Study assessment | d 1
|
d 2
|
||||
---|---|---|---|---|---|---|
1800 h | 2200 h | 0600 h | 1200 h | 1800 h | 2200 h | |
ACTH measurement | Ö | Ö | ||||
Dexamethasone 1 mg orally | Ö | Ö | Ö | Ö | Ö | |
20a Subjects dosed with MR-HC 5, 15, or 30 mg, or IR-HC 10 mg | ||||||
12 Subjects dosed with MR-HC 10 mg or IR-HC 10 mg | Ö |
Subjects were admitted to the Clinical Research Facility on d 1, and were tested on up to three occasions with a 1-wk washout between treatments. Cortisol measurement, pre-dose at 2200 h and post-dose sampling every 30 minutes for the first 4 h, then at 5, 6, 7, 8, 10, 12, 15, 18, and 24 h after dose.
Four subjects withdrawn.